This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Agiliti (AGTI) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Agiliti (AGTI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agiliti (AGTI) Q4 Earnings Beat Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of 8.33% and 0%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Agiliti (AGTI) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Agiliti (AGTI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Agiliti (AGTI): Can Its 29.1% Jump Turn into More Strength?
by Zacks Equity Research
Agiliti (AGTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Analyzing 3 Healthcare Stocks Poised for Q4 Earnings Beat
by Kaibalya Pravo Dey
Rising patient volumes, admissions, health awareness and technological advancements in the Q4 are likely to have benefited healthcare players like Universal Health (UHS), Alignment Healthcare (ALHC) and Agiliti (AGTI).
Strength Seen in NovoCure (NVCR): Can Its 16.8% Jump Turn into More Strength?
by Zacks Equity Research
NovoCure (NVCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Agiliti (AGTI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Agiliti (AGTI) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agiliti (AGTI) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Agiliti (AGTI) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agiliti (AGTI) Q2 Earnings Lag Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of -6.67% and 2.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Progyny (PGNY) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Progyny (PGNY) delivered earnings and revenue surprises of 50% and 6.57%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Agiliti (AGTI) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Agiliti (AGTI) stock based on the movements in the options market lately.
Agiliti (AGTI) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of 17.65% and 5.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
DocGo Inc. (DCGO) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
DocGo Inc. (DCGO) delivered earnings and revenue surprises of -200% and 1.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Agiliti (AGTI) Q4 Earnings Meet Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of 0% and 3.40%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sotera Health Company (SHC) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Sotera Health Company (SHC) delivered earnings and revenue surprises of 13.64% and 1.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Agiliti (AGTI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Agiliti, Inc. (AGTI) stock based on the movements in the options market lately.
Agiliti (AGTI) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of 5.56% and 1.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of -150% and 1.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Agiliti (AGTI) Q3 Earnings Expected to Decline
by Zacks Equity Research
Agiliti (AGTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Agiliti (AGTI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Agiliti (AGTI) stock based on the movements in the options market lately.
Agiliti (AGTI) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of -5% and 4.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
ModivCare (MODV) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ModivCare (MODV) delivered earnings and revenue surprises of 39.16% and 7.99%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Anthem (ELV) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Anthem (ELV) delivered earnings and revenue surprises of 4.15% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Agiliti (AGTI) Stock Jumps 5.5%: Will It Continue to Soar?
by Zacks Equity Research
Agiliti (AGTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Agiliti (AGTI) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Agiliti (AGTI) delivered earnings and revenue surprises of 26.09% and 0.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?